Culmerciclib in HR+/HER2+ Advanced Breast Cancer

Clinical trial NCT07732491 · RECRUITING

Trial details

NCT number: NCT07732491
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastastic Breast Cancer HER2+ Advanced Breast Cancer

Start date: 2026-08-01
Primary completion: 2028-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.